12:00 AM
Jul 27, 2009
 |  BC Week In Review  |  Company News  |  Deals

Forma Therapeutics Inc., LLS deal

Forma will use its Computation Solvent Mapping technology to optimize and prioritize 10 small molecules from the...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >